The diagnostic role of autoantibodies in the prediction of organ-specific autoimmune diseases
- 1 January 2008
- journal article
- review article
- Published by Walter de Gruyter GmbH in cclm
- Vol. 46 (5) , 577-587
- https://doi.org/10.1515/cclm.2008.138
Abstract
Due to their pathogenetic role, many serum autoantibodies can be detected a long time before the clinical onset and during the course of organ-specific autoimmune diseases. For these reasons, autoantibodies can be used as predictive markers of an ongoing disease (in healthy subjects) and of disease activity and severity (in ill patients). The new multiplex diagnostic technologies introduced recently in laboratory medicine allow the simultaneous detection of several different autoantibodies and can be used for screening purposes in open populations or high-risk groups. This review examines the various autoantibodies of demonstrated predictive role in organ-specific autoimmune diseases and it introduces the state-of-the-art in the detection of multiple autoantibodies with proteomic systems.Keywords
This publication has 100 references indexed in Scilit:
- New serological markers in inflammatory bowel disease are associated with complicated disease behaviourGut, 2007
- Epidemiology of autoimmune diseases in DenmarkJournal of Autoimmunity, 2007
- Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathyInternational Journal of Cardiology, 2004
- A prospective study of the incidence of childhood celiac diseaseThe Journal of Pediatrics, 2003
- Prospective Study of the Spontaneous Course of Subclinical Hypothyroidism: Prognostic Value of Thyrotropin, Thyroid Reserve, and Thyroid AntibodiesJournal of Clinical Endocrinology & Metabolism, 2002
- The Karlsburg Type 1 Diabetes Risk Study of a Normal Schoolchild Population: Association of -Cell Autoantibodies and Human Leukocyte Antigen-DQB1 Alleles in Antibody-Positive IndividualsJournal of Clinical Endocrinology & Metabolism, 2002
- DRB104 and DQ Alleles: Expression of 21-Hydroxylase Autoantibodies and Risk of Progression to Addison's DiseaseJournal of Clinical Endocrinology & Metabolism, 1999
- Anti-M2 muscarinic receptor autoantibodies and idiopathic dilated cardiomyopathyInternational Journal of Cardiology, 1996
- Remission of subclinical adrenocortical failure in subjects with adrenal autoantibodiesJournal of Clinical Endocrinology & Metabolism, 1993
- COMPLEMENT-FIXING ADRENAL AUTOANTIBODIES AS A MARKER FOR PREDICTING ONSET OF IDIOPATHIC ADDISON'S DISEASEThe Lancet, 1983